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Abstract 
Bioreactors that subject cell seeded scaffolds or hydrogels to biophysical stimulation 
have been used to improve the functionality of tissue engineered cartilage and to 
explore how such constructs might respond to the application of joint specific 
mechanical loading. Whether a particular cell type responds appropriately to 
physiological levels of biophysical stimulation could be considered a key determinant 
of its suitability for cartilage tissue engineering applications. The objective of this 
study was to determine the effects of dynamic compression on chondrogenesis of 
stem cells isolated from different tissue sources. Porcine bone marrow (BM) and 
infrapatellar fat pad (FP) derived stem cells were encapsulated in agarose hydrogels 
and cultured in a chondrogenic medium in free swelling (FS) conditions for 21 days, 
after which samples were subjected to dynamic compression (DC) of 10% strain (1Hz, 
1 hour/day) for a further 21 days. Both BM derived stem cells (BMSCs) and FP 
derived stem cells (FPSCs) were capable of generating cartilaginous tissues with near 
native levels of sulfated glycosaminoglycan (sGAG) content, although the spatial 
development of the engineered grafts strongly depended on the stem cell source. The 
mechanical properties of cartilage grafts generated from both stem cell sources also 
approached that observed in skeletally immature animals. Depending on the stem cell 
source and the donor, the application of DC either enhanced or had no significant 
effect on the functional development of cartilaginous grafts engineering using either 
BMSCs or FPSCs. BMSC seeded constructs subjected to DC stained less intensely for 
collagen type I. Furthermore, histological and micro-computed tomography analysis 
showed mineral deposition within BMSCs seeded constructs was suppressed by the 
application of DC. Therefore, while the application of DC in vitro may only lead to 
modest improvements in the mechanical functionality of cartilaginous grafts, it may 
play an important role in the development of phenotypically stable constructs.  
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Introduction 
Adult stem cells represent a promising cell source for cartilage tissue engineering, due 
to their chondrogenic potential and rapid self-renewing ability. They have been 
identified in various tissues, such as bone marrow (BM) (Pittenger et al., 1999, 
Johnstone et al., 1998, Yoo et al., 1998), adipose tissue (Erickson et al., 2002, Gimble 
and Guilak, 2003, Guilak et al., 2004), infrapatellar fat pad (FP) (Dragoo et al., 2003, 
Wickham et al., 2003, English et al., 2007) and synovium (Pei et al., 2008, Pei et al., 
2009, Vinardell et al., 2012b), among which BM derived stem cells (BMSCs) are 
perhaps the most extensively studied cell type. Various studies have demonstrated 
successful chondrogenic induction of BMSCs in a number of different biomaterials, 
including naturally derived materials (e.g., collagen, hyaluronic acid, alginate, agarose) 
(Matsiko et al., 2012, Bian et al., 2011, Li et al., 2009, Thorpe et al., 2010) and 
synthetic materials (e.g., polyglycolic acid (PGA) and polycaprolactone (PCL)) 
(Kafienah et al., 2007, Wise et al., 2009) among others. In spite of their tremendous 
promise, there are a number of potential limitations associated with BMSC based 
tissue engineering strategies for articular cartilage repair. Firstly, it has been 
demonstrated that cartilage engineered using BMSCs has inferior biochemical and 
biomechanical properties to that engineered using primary chondrocytes (Erickson et 
al., 2009, Mauck et al., 2006). Furthermore, studies have also shown that cartilage 
tissues engineered using BMSCs have the potential to undergo hypertrophy and 
endochondral ossification (Kafienah et al., 2007, Pelttari et al., 2006). This has 
motivated the use of alternative stem cell sources for cartilage tissue engineering. 
Compared to BMSCs, stem cells isolated from the infrapatellar fat pad (FP) of the 
knee are arguably easier to isolate, with a lower degree of invasiveness and minimal 
patient morbidity (Dragoo et al., 2003). FP derived stem cells (FPSCs) have 
successfully been used for engineering cartilaginous tissues (Buckley and Kelly, 2012, 
Buckley et al., 2010a, Buckley et al., 2010b, Liu et al., 2013, Liu et al., 2012, Jurgens 
et al., 2009, Felimban et al., 2014, Ye et al., 2014), with such grafts demonstrating at 
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least comparable functionality to those generated using BMSCs (Vinardell et al., 
2011). Furthermore, studies have shown that cartilage grafts engineered using FPSCs 
have a lower tendency to undergo endochondral ossification compared to those 
engineered using BMSCs (Vinardell et al., 2012b). 
Physiologically, articular cartilage exists in a complex biomechanical environment, 
being subjected to cyclical deformational loading and large hydrostatic pressures 
during joint movement (Mow and Wang, 1999). It has been demonstrated that 
mechanical cues play an important role in the development (Mikic et al., 2000, Mikic 
et al., 2004), remodeling (Rieppo et al., 2009) and repair of this tissue (Wakitani et al., 
1994). More recently, dynamic compression has been explored as a potential stimulus 
to enhance chondrogenesis for cartilage tissue engineering applications. Numerous 
studies have demonstrated that dynamic compression can increase cartilage-specific 
matrix synthesis by chondrocytes (Demarteau et al., 2003, Mauck et al., 2000, 
Buschmann et al., 1995). Moreover, dynamic compression has also been shown to 
regulate chondrogenesis of BMSCs at both the gene and protein level (Huang et al., 
2005, Haugh et al., 2011, Kelly and Jacobs, 2010, Thorpe et al., 2008, Thorpe et al., 
2010, Li et al., 2010a, Li et al., 2010b), with increased sulfated glycosaminoglycan 
(sGAG) accumulation reported in BMSCs seeded hydrogels following the application 
of loading (Mauck et al., 2007, Kisiday et al., 2009, Thorpe et al., 2013). Such 
mechanical stimulation protocols have also been shown to improve the mechanical 
properties of BMSC seeded cartilage constructs (Huang et al., 2010, Thorpe et al., 
2013, Bian et al., 2012). 
Understanding how cartilaginous tissues engineered using stem cells will respond to 
the local mechanical environment will be critical to successful clinical cartilage repair. 
While a number of studies have shown that dynamic compression can promote 
chondrogenesis of BMSCs, to the best of our knowledge no study to date has 
compared the response of stem cells isolated from different tissue sources to this 
biophysical stimulus. Therefore, the objective of this study was to compare the effects 
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of dynamic compression on chondrogenesis of BMSCs and FPSCs that were 
encapsulated in agarose hydrogels. We hypothesized that dynamic compression would 
enhance the functional development of cartilaginous tissues engineered using stem 
cells independent of their origin. To test this hypothesis, porcine BMSCs and FPSCs 
were encapsulated in agarose hydrogels and cultured in the presence of TGF-β3 for 3 
weeks before being subjected to dynamic compression of 10% strain (1Hz, 1 hour/day) 
for a further 3 weeks. We first investigated the temporal and spatial development of 
cartilage grafts engineered in free swelling culture using stem cells of different origin, 
and then investigated the influence of dynamic compression on: 1) cartilage specific 
matrix accumulation and the subsequent mechanical properties of the engineered 
tissue; 2) the spatial distribution of matrix within the engineered tissue; and 3) the 
tendency of stem cell seeded cartilage constructs to undergo hypertrophy and to begin 
to calcify. 
Materials and Methods 
Cell Isolation and Expansion 
Porcine BMSCs were obtained from the bone marrow of the femur and FPSCs from 
the entire infrapatellar fat pad of the knee joint (n=2, 3-4 months old, ∼50kg). The 
isolation of these cells from porcine donors was approved by the ethics board of 
Trinity College Dublin (Dublin, Ireland) and the procedures were conducted 
according to local guidelines. BMSCs were isolated using an adapted protocol used 
for human BMSCs isolation (Lennon and Caplan, 2006) and FPSCs were isolated as 
previously described (Buckley and Kelly, 2012). After isolation, BMSCs and FPSCs 




 in high-glucose Dulbecco’s modified
Eagle’s medium (hgDMEM) GlutaMAX
TM
 supplemented with 10% fetal bovine
serum and 1% penicillin (100 U/mL)-streptomycin (100 µg/mL) (all GIBCO, 
Biosciences, Dublin, Ireland) and expanded to passage two (P2) in a humidified 
atmosphere of 5% CO2 at 37
◦
C. For both BMSCs and FPSCs, 5 ng/ml
fibroblast-growth factor-2 (ProSpec-Tany TechnoGene Ltd, Israel) was added into the 
medium (from the beginning of P0 for FPSCs; from the beginning of P1 for BMSCs) 
to promote the growth and chondrogenic potential of stem cells (Buckley and Kelly, 
2012).  
Hydrogel construct fabrication and culturing 
BMSCs and FPSCs (both P2) were encapsulated respectively in agarose (Type VII) as 
previously described (Thorpe et al., 2010) to obtain a final gel concentration of 2% 
and a cell density of 30 x 10
6
 cells/ml. The agarose-gel suspension was then cast into
a stainless steel mold from which cylindrical constructs (Ø6 mm × 4 mm thickness) 
were removed using a biopsy punch. Constructs were then maintained separately in 
6-well-plates in 9 ml of chondrogenic medium (per construct) consisting of hgDMEM
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GlutaMAX
TM
 supplemented with penicillin (100 U/ml)-streptomycin (100 µg/ml), 
100 µg/ml sodium pyruvate, 40 µg/ml L-proline, 4.7 µg/mL linoleic acid, 50 µg/ml 
L-ascorbic acid-2-phosphate, 1.5 mg/ml bovine serum albumin, 1 × insulin–
transferrin–selenium, 100 nM dexamethasone (all from Sigma-Aldrich, Dublin, 
Ireland) and 10 ng/ml recombinant human transforming growth factor-β3 (TGF-β3; 
ProSpec-Tany TechnoGene Ltd). Media was exchanged twice weekly. At each 
exchange, media was sampled and stored at -85
◦
C for biochemical analysis.
Experimental design 
Cell seeded hydrogels (generated using BMSCs and FPSCs) were first maintained in 
free swelling (FS) conditions in a chondrogenic medium for 21 days to allow 
differentiation toward a chondrogenic phenotype and matrix establishment (Haugh et 
al., 2011). At this point, half of the samples were subjected to dynamic compression 
(DC) of 10% strain (1Hz, 1 hour/day, 5 days/week) for a further 21 days as previously 
described (Thorpe et al., 2010), while the remaining samples were maintained in FS 
conditions to serve as a control. We chose this delayed loading protocol, since 
previous studies have shown that applying DC immediately after cell encapsulation 
can suppress chondrogenesis of BMSCs, whereas delayed application of DC leads to 
enhanced chondrogenesis (Thorpe et al., 2010, Thorpe et al., 2013). Constructs (n=6 
per group) were assessed at day 0, 21 and 42. This experiment was repeated again 
using cells isolated from a different donor.  
Assessment of mechanical properties 
Construct mechanical properties were tested (n=4 per group) using a standard 
materials testing machine with a 5N load cell (Zwick Roell Z005, Herefordshire, UK) 
as previously described (Buckley et al., 2009). Briefly, constructs were immersed in 
phosphate buffered saline (PBS) bath (room temperature) and placed between two 
impermeable platens. A preload of 0.01 N was used to ensure direct contact between 
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construct and platen surfaces. An unconfined stress-relaxation test was then 
performed, which consisted of a ramp compression up to 10% strain of the sample 
thickness followed by a hold period of 30 minutes until equilibrium was reached. The 
equilibrium compressive modulus of the sample was calculated from the equilibrium 
force. A dynamic test consisting of a cyclic strain amplitude of 1% at 1 Hz for 10 
cycles was performed directly after the equilibrium test to determine the dynamic 
modulus.  
Quantitative biochemical analysis 
Construct analysis 
After mechanical testing, constructs were maintained in PBS for 30 mins to allow 
them to recover to their initial thickness, after which constructs (n=3/4 per group) 
were transversely sliced into two halves for determination of the spatial distribution of 
matrix within the engineered tissue. The top and bottom halves of the samples were 
weighed (wet) and stored separately at -85 
◦
C for subsequent analyses. Samples were 
digested with 125 µg/ml papain in 0.1 M sodium acetate, 5 mM L-cysteine HCl, 0.05 
M EDTA, pH 6.0 (all Sigma-Aldrich) under constant rotation at 60 
◦
C for 18 hours. 
The DNA content of the samples was measured using the Hoechst bisBenzimide 
H33258 dye assay with calf thymus DNA as a standard as previously described (Kim 
et al., 1988). sGAG content was quantified using the dimethylmethylene blue 
dye-binding assay (Blyscan, Biocolor Ltd., Northern Ireland), with a chondroitin 
sulfate standard. Collagen content was determined through measurement of the 
hydroxyproline content (Kafienah and Sims, 2004) and calculated using a 
hydroxyproline-to-collagen ratio of 1:7.69 (Ignat’eva et al., 2007). Matrix 
accumulation (sGAG and collagen) were normalized to construct wet weight and to 
DNA content. 
Media analysis 
Aliquots sampled at each media exchange from day 21 to day 42 were analyzed for 
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total sGAG or collagen content secreted into the media during this period using the 
methods described above. Total medium volume was accounted for and data is 
presented as average sGAG or collagen content released per construct into media 
from day 21 to day 42. Media samples from day 21 to day 42 were also analyzed for 
alkaline phosphatase (ALP) activity using a Sensolyte pNPP Alkaline Phosphatase 
assay kit (Cambridge Biosciences, UK) with a calf intestine ALP standard (Sheehy et 
al., 2012). 
Histology and immunohistochemistry 
Whole constructs (n=2 per group) were fixed with 4% paraformaldehyde 
(Sigma-Aldrich), wax embedded and sectioned perpendicularly to the disk surface at a 
thickness of 5 µm. Sections were stained histologically with 1% alcian blue 8GX in 
0.1M HCl for sGAG distribution, picrosirius red for collagen distribution and 1% 
alizarin red for mineral deposition (all Sigma–Aldrich). Sections were also 
immunohistochemically stained for collagen type I and II using a mouse monoclonal 
collagen type I antibody (1:100; 1.4 mg/mL; Abcam, Cambridge, UK) and a mouse 
monoclonal collagen type II antibody (1:80; 1 mg/mL; Abcam) respectively as 
previously described (Thorpe et al., 2010). Sections of porcine cartilage and ligament 
were included as controls.  
Micro-computed tomography analysis 
Constructs (n=2 per group) were scanned using micro-computed tomography (µCT) 
in order to assess the mineral content and distribution within the samples. Scans were 
performed using a Scanco Medical µCT 40 system (Scanco Medical, Bassersdorf, 
Switzerland) at a voltage of 70 kVp and a current of 114 µA. Data is presented as the 
volume of mineral within each construct. A 3-dimensional (3D) image of the mineral 
deposition within the constructs was also obtained from the system. 
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Statistical analysis 
Statistics were performed using MINITAB 15.1 software (Minitab Ltd., Coventry, 
UK). For data where two factors of comparison (day 21 vs. 42 and/or BM vs. FP 
and/or top vs. bottom and/or FS vs. DC) were required, a general lineal model for 
analysis of variance with Tukey’s test for multiple comparisons was used. For direct 
comparison between FS and DC group, a two-sample T-test was used. Significance 
was determined at p≤0.05 and a trend towards significance was defined as p≤0.1. All 
graphical results are presented as mean ± standard deviation.   
Results
Temporal and spatial development of cartilage grafts engineered in free swelling 
culture using different sources of stem cells  
We first investigated the temporal development of cartilaginous constructs engineered 
using both BM and FP derived stem cells in free swelling (FS) culture. A significant 
increase in DNA content was observed in FP constructs from day 21 to day 42 
(p<0.05), indicating cell proliferation, while the DNA content of BM constructs 
remained relatively constant over the same culture period (Fig. 1A). A significant 
increase in sGAG and collagen content from day 21 to day 42 was also seen in both 
BM constructs and FP constructs (p<0.05; Fig. 1A). At day 42, the sGAG content in 
BM constructs was ∼2% (w/w), compared to ∼3% (w/w) in FP constructs. The 
collagen content was significantly higher in BM constructs compared to FP constructs 
(p<0.05; Fig. 1A).   
Histological staining was used to examine the spatial distribution of matrix within the 
FS constructs at day 42. Compared to FP constructs, a relatively homogeneous 
distribution of sGAG and collagen was observed throughout the depth of BM 
constructs, although the core of the engineered tissue did stain slightly more intensely 
for glycosaminoglycans (Alcian Blue) and type II collagen (Fig. 1B). This was further 
confirmed through biochemical quantification of the matrix content in the top and 
bottom halves of the constructs, with similar levels of DNA, sGAG and collagen 
observed in the top and bottom of the BM constructs (data not shown). A more 
heterogeneous distribution of matrix was observed in FP constructs, with decreased 
sGAG and collagen accumulation through the depth of the engineered tissue (and also 
from periphery towards core; Fig. 1B). Biochemical data also confirmed a 
significantly higher level of sGAG and collagen content in the top compared the 
bottom of FP constructs, although no significant difference in DNA content between 
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∼300 kPa and ∼1400 kPa respectively (Figs. 2M, 2N). DC significantly enhanced the
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top and bottom of the engineered tissue was observed (data not shown). 
Immunohistochemical analysis showed a strong staining for collagen type II in BM 
constructs at day 42, while a weaker staining was found in FP constructs (Fig. 1B). 
Positive staining for collagen type I was also observed in the peripheral region of the 
BM constructs (albeit staining less intensely than for collagen type II). FP constructs 
stained weakly for collagen type I (Fig. 1B). 
In a replicate of this experiment, where BM and FP constructs were fabricated using 
cells isolated from another donor, similar temporal and spatial matrix development 
was observed again for each construct type. However, higher sGAG accumulation 
(∼4% (w/w)) was observed in BM constructs engineered using the second donor. The 
sGAG content in FP constructs engineered using this donor remained ∼3% (w/w) 
(Supplementary Fig. 1).  
The influence of dynamic compression on the functional properties of cartilage 
grafts engineered using different sources of stem cells  
To assess the effects of delayed dynamic compression (DC) on chondrogenesis of BM 
and FP stem cell seeded constructs, samples were first cultured in a chondrogenic 
medium in FS conditions for 3 weeks (day 0-21) to allow differentiation toward a 
chondrogenic phenotype and matrix establishment, before subjection to DC for a 
further 3 weeks (day 21-42). DC lead to a small but statistically significant increase in 
sGAG (p<0.05; Figs. 2B, 2D) and collagen (p<0.05; Figs. 2C, 2E) accumulation in 
BM constructs. For FP constructs, DC didn’t significantly alter any of the biochemical 
constituents of the engineered tissue (Figs. 2 H-L). At day 42, the equilibrium and 
dynamic modulus of BM constructs maintained in FS culture conditions was ∼70 kPa 
and ∼700 kPa respectively (Figs. 2F, 2G); while the equilibrium and dynamic 
modulus of FP constructs maintained in FS culture conditions was notably higher at 
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equilibrium and dynamic modulus of BM constructs (p<0.001; Figs. 2F, 2G), however 
it had no significant effect on the mechanical properties of the FP constructs (Figs. 
2M, 2N).  
sGAG and collagen accumulation within the hydrogels, and that released into medium 
during the loading period (day 21-42), was also assessed in order to examine the 
direct influence of DC on absolute levels of extracellular matrix (ECM) synthesis. 
Higher levels of sGAG release into the medium was observed in BM constructs with 
the application of loading, such that DC significantly enhanced total amount of sGAG 
synthesis (accumulated + released) over the loading period (p<0.01; Fig. 3A). The 
total amount of collagen synthesis in BM constructs over this period was, however, 
not affected by the application of DC (Fig. 3B). For FP constructs, no significant 
difference in sGAG or collagen synthesis was observed between the FS and DC 
samples (Figs. 3C, 3D).  
In a replicate using stem cells from a different donor, DC was found to have no 
significant effect on the bulk biochemical composition or the mechanical properties of 
either BM or FP grafts (supplementary Fig. 2). Similarly, in this experiment DC did 
not significantly alter the total sGAG or collagen synthesis (accumulated + released) 
over the loading period (data not shown). 
Histological analysis showed no obvious difference in staining intensity for sGAG or 
collagen, at the macroscopic level, between FS and DC samples for either BM or FP 
constructs engineered from either donor (Fig. 4 and supplementary Fig. 3). Similarly, 
DC did not appear to influence collagen type II accumulation. Moderate staining for 
collagen type I was found in the peripheral region of FS cultured BM constructs 
engineered from both donors; however, less intense staining was observed in BM 
constructs subjected to DC for both donors (Fig. 4 and supplementary Fig. 3). FP 
constructs stained weakly for collagen type I regardless of the loading condition. 
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The influence of DC on the spatial development of engineered cartilage 
Overall, the application of DC did not dramatically alter the spatial accumulation of 
sGAG or collagen in the top and bottom of engineered tissues (Fig. 5 A-F), although 
matrix distribution appeared more homogeneous in FP constructs engineered from 
donor 2 (Fig. 5G, 5H). Histological staining revealed that the peripheral of engineered 
BM constructs stained weakly for sGAG under FS conditions. The pericellular region 
of cells in this region of loaded BM constructs appeared to be richer in sGAGs 
(supplementary Fig. 4).  
The influence of DC on hypertrophy of chondrogenically primed BMSCs 
Alizarin red staining and µCT scans were carried out to assess mineralization of the 
engineered cartilaginous constructs. At day 42, positive staining was found in FS 
cultured BM constructs from both donors, while tissues subjected to DC stained less 
intensively or negatively (Fig. 6A). Despite this, no significant difference in ALP 
activity in the media of FS and DC constructs was found (data not shown). µCT scans 
revealed variable mineral deposition within the constructs (Fig. 6B), and in general 
less mineral accumulation was observed in DC samples compared to FS controls (Fig. 
6C). In contrast, no evidence of mineralization was observed in FP constructs (Fig. 
6A). Furthermore, no ALP activity was measured in the culture media (data not 
shown).  
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Discussion 
The overall objective of this study was to explore how dynamic compression (DC) 
would influence the functional development of cartilaginous grafts engineered using 
different sources of stem cells. In agreement with previous studies (Huang et al., 2010, 
Bian et al., 2012, Thorpe et al., 2013, Mauck et al., 2007, Kisiday et al., 2009), we 
showed the application of DC can be beneficial to the development of cartilaginous 
grafts engineered using BMSCs, with loading having the potential to increase matrix 
accumulation and the mechanical properties of the graft while simultaneously 
suppressing collagen type I accumulation and mineral deposition. In contrast, DC did 
not have a dramatic effect on the functional development of cartilaginous grafts 
engineered using FPSCs, with no significant changes observed in matrix synthesis or 
mechanical properties of engineered tissues subjected to loading.   
Stem cells isolated from both BM and FP tissue generated cartilaginous constructs 
with a proteoglycan content, measured as a percentage of wet weight, approaching 
that observed in the skeletally immature tissue (Gannon et al., 2012). This in turn led 
to the development of tissues with mechanical properties of a similar order of 
magnitude to native skeletally immature tissue, with the equilibrium modulus 
reaching up to 300kPa (see Fig. 2 and Supplementary Fig. 2). Perhaps the most 
striking difference between the tissues engineered using BM and FP derived stem 
cells was the spatial accumulation of matrix within the hydrogel. Greater levels of 
extracellular matrix (ECM) accumulation were observed around the periphery of FP 
constructs from both donors, while a more homogenous distribution of ECM was 
observed in BM constructs (see Fig. 1B and Supplementary Fig. 1B). This may be due 
to the fact that FPSCs were more metabolically active than BMSCs, leading to the 
development of nutrient deprived regions towards the center of the FP constructs. The 
greater levels of proliferation observed in FP constructs (Fig. 1A) may also be 
contributing to the development of such a nutrient deprived core region in the 
engineered tissue. Alternatively, it may be possible that nutrient deprived regions 
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develop in the center of both FP and BM constructs, but that BMSCs are better 
equipped to thrive in such conditions than FPSCs. Evidence against this hypothesis 
can be found in recent studies which demonstrate that BMSCs are sensitive to nutrient 
supply and undergo superior chondrogenesis under optimal nutrient conditions 
(Farrell et al., 2012), although direct comparisons of different stem cell types in 
nutrient deprived conditions have yet to be undertaken. Further studies are required to 
compare the metabolic requirements of different sources of stem cells, as if 
differences do exist then the culture conditions required to engineer functional 
cartilage grafts will need to be optimized for specific stem cell types. 
Dynamic compression did not appear to enhance the development of cartilage grafts 
engineered using FPSCs. This may be due to the fact that these cells possess a strong 
intrinsic potential to generate a matrix rich in proteoglycans following TGF-β3 
stimulation (generating tissues with a sGAG content approaching that of native 
skeletal immature articular cartilage), and hence chondrogenesis of FPSCs is not 
further enhanced following the application of DC. Furthermore, when DC was 
observed to increase ECM synthesis in BM constructs, these changes were relatively 
small. As previous studies provide support for the hypothesis that mechanical load 
promotes chondrogenesis of human mesenchymal stem cells through the TGF-β 
pathway by up-regulating TGF-β gene expression and protein synthesis (Li et al., 
2010a), it is perhaps unsurprising that dynamic compression has only a small effect on 
ECM synthesis in culture environment containing abundant TGF-β3. Further work is 
required to identify if alternative loading periods or magnitudes would have a more 
positive impact on chondrogenesis of FP derived stem cells.  
The spatial differences in ECM accumulation observed in BM and FP constructs (and 
indeed between stem cells taken from the same tissue source but from different 
donors) may provide an alternative explanation for why DC did not consistently result 
in an increase in matrix synthesis. Finite element models have demonstrated that 
localization of ECM to the outer layer of the engineered tissue, similar to that 
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observed in FP constructs from both donors, can result in an order of magnitude 
change in the peak volumetric strain and deviatoric strain in the tissue, and to reduce 
the peak pore pressure in the centre of the construct (Khoshgoftar et al., 2013). 
Therefore the spatial mechanical environment within the FP and BM grafts are likely 
very different, even though the same global deformation is being applied to each 
engineered tissue. It is therefore possible that the more homogenous ECM distribution 
observed in the BMSCs seeded construct is leading to the development of a more 
chondrogenic mechanical environment (at least in parts of the construct) when these 
tissues are subjected to DC. Similarly, donor to donor variability in the response of 
BMSCs to loading may also potentially be explained by variations in ECM 
accumulation. The fact that BMSCs from donor 1 responded anabolically to the 
application of DC, while donor 2 did not, may also be due to the greater levels of 
ECM accumulation observed in the grafts generated from donor 2 (sGAG 
accumulation was approximately two fold higher for donor 2; see Fig. 1A and 
Supplementary Fig. 1A). Such differences may necessitate alterations to the 
magnitude of global deformation applied to a given engineered tissue as it develops to 
create a pro-chondrogenic mechanical environment at the cellular level (Khoshgoftar 
et al., 2013). These results also serve to highlight the challenges of further exploring 
donor dependent variability in the response of stem cells to biophysical cues, which is 
beyond the scope of the present study. Given that spatial ECM accumulation 
determines the local cellular mechanical environment in engineered tissues subjected 
to DC, and that ECM develops uniquely with the engineered tissue of each donor, it is 
difficult if not impossible to attribute differences in matrix synthesis in response to 
DC between the different donors to either donor dependent stem cell 
mechano-responsiveness, differences in ECM accumulation between donors or a 
combination of both.   
It was found that a small, but significant, increase in sGAG and collagen 
accumulation (∼8% increase in sGAG and collagen accumulation with the application 
of DC) led to a relatively higher increase (∼25%) in the equilibrium modulus of the 
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BM constructs (Fig. 2). Previous studies have found that the delayed application of 
dynamic compression to cartilaginous tissues engineered using BMSCs can lead to 
improvements in the mechanical properties of the grafts without significantly 
changing the bulk levels of sGAG and collagen accumulation within the tissue 
(Huang et al., 2010). DC did however lead to an altered distribution of matrix 
components within the engineered tissue, which may in turn contribute to the 
improved apparent mechanical properties (Huang et al., 2010). While such dramatic 
changes in ECM distribution were not observed in this study, which may be due to the 
fact that we only applied 1 hour of DC compared to 4 hours used in other studies, 
subtle changes in pericellular sGAG accumulation were observed following the 
application of loading. Any loading regime that leads to the development of a more 
homogenous engineered tissue should lead to an increase in the apparent mechanical 
properties independent of any increase in biochemical composition (Khoshgoftar et al., 
2012).  
In agreement with a number of recent studies (Thorpe et al., 2012, Bian et al., 2012, 
Vinardell et al., 2012a, Steward et al., 2012), we also found that mechanical cues 
would appear to be critical to the maintenance of the cartilage phenotype in 
chondrogenically primed BMSCs. Collagen type I accumulation and mineralization 
within BM constructs was suppressed by the application of DC. This suggests that 
much of the concern associated with hypertrophy and endochondral ossification of 
chondrogenically primed BMSCs could be associated with the absence of mechanical 
cues within most in vitro culture conditions and many in vivo models (such as 
subcutaneous implantation) used to access the phenotypic stability of tissue 
engineered grafts. Under the appropriate mechanical environment within load bearing 
cartilage defects, it may be that BMSCs will generate phenotypically stable articular 
cartilage (Steck et al., 2009). In contrast, cartilage constructs engineered using FPSCs 
did not exhibit any mineralization. This is in line with other findings that FPSCs have 
a lower tendency to proceed endochondral pathway compared to BMSCs (Vinardell et 
al., 2012b). 
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In conclusion, both BM and FP derived stem cells were capable of generating 
cartilaginous tissues with near native levels of sGAG content and mechanical 
properties approaching that observed in skeletally immature animals. Collagen 
accumulation, as has been observed in numerous cartilage tissue engineering studies, 
was still significantly lower than the native tissue. The application of dynamic 
compression could at best lead to small increases in ECM accumulation, although not 
for all donors or cell types. Based on the results of this study, it is difficult to argue 
that such small increases in ECM synthesis would warrant the use of bioreactors in a 
clinical context for cartilage regeneration. Whether the potential increases in 
mechanical properties of the graft, or the suppression of hypertrophy, merits their use 
requires further in vivo studies.  
Acknowledgements 
Funding was provided by the European Research Council Starter Grant (StemRepair – 
Project number 258463) and a SFI President of Ireland Young Researcher Award 
(08/Y15/B1336).  
References 
BIAN, L., ZHAI, D. Y., TOUS, E., RAI, R., MAUCK, R. L. & BURDICK, J. A. 2011. Enhanced MSC 
chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic 
acid hydrogels in vitro and in vivo. Biomaterials, 32, 6425-6434. 
BIAN, L., ZHAI, D. Y., ZHANG, E. C., MAUCK, R. L. & BURDICK, J. A. 2012. Dynamic compressive loading 
enhances cartilage matrix synthesis and distribution and suppresses hypertrophy in 
hMSC-laden hyaluronic acid hydrogels. Tissue Eng Part A, 18, 715-24. 
BUCKLEY, C. T. & KELLY, D. J. 2012. Expansion in the presence of FGF-2 enhances the functional 
development of cartilaginous tissues engineered using infrapatellar fat pad derived MSCs. J 
Mech Behav Biomed Mater, 11, 102-11. 
BUCKLEY, C. T., THORPE, S. D., O'BRIEN, F. J., ROBINSON, A. J. & KELLY, D. J. 2009. The effect of 
concentration, thermal history and cell seeding density on the initial mechanical properties 
of agarose hydrogels. J Mech Behav Biomed Mater, 2, 512-21. 
BUCKLEY, C. T., VINARDELL, T. & KELLY, D. J. 2010a. Oxygen tension differentially regulates the 
functional properties of cartilaginous tissues engineered from infrapatellar fat pad derived 
MSCs and articular chondrocytes. Osteoarthritis Cartilage, 18, 1345-54. 
BUCKLEY, C. T., VINARDELL, T., THORPE, S. D., HAUGH, M. G., JONES, E., MCGONAGLE, D. & KELLY, D. J. 
2010b. Functional properties of cartilaginous tissues engineered from infrapatellar fat 
pad-derived mesenchymal stem cells. J Biomech, 43, 920-6. 
BUSCHMANN, M. D., GLUZBAND, Y. A., GRODZINSKY, A. J. & HUNZIKER, E. B. 1995. Mechanical 
compression modulates matrix biosynthesis in chondrocyte/agarose culture. J Cell Sci, 108 
( Pt 4), 1497-508. 
DEMARTEAU, O., WENDT, D., BRACCINI, A., JAKOB, M., SCHAFER, D., HEBERER, M. & MARTIN, I. 2003. 
Dynamic compression of cartilage constructs engineered from expanded human articular 
chondrocytes. Biochem Biophys Res Commun, 310, 580-8. 
DRAGOO, J. L., SAMIMI, B., ZHU, M., HAME, S. L., THOMAS, B. J., LIEBERMAN, J. R., HEDRICK, M. H. & 
BENHAIM, P. 2003. Tissue-engineered cartilage and bone using stem cells from human 
infrapatellar fat pads. J Bone Joint Surg Br, 85, 740-7. 
ENGLISH, A., JONES, E. A., CORSCADDEN, D., HENSHAW, K., CHAPMAN, T., EMERY, P. & MCGONAGLE, D. 
2007. A comparative assessment of cartilage and joint fat pad as a potential source of cells 
for autologous therapy development in knee osteoarthritis. Rheumatology (Oxford), 46, 
1676-83. 
ERICKSON, G. R., GIMBLE, J. M., FRANKLIN, D. M., RICE, H. E., AWAD, H. & GUILAK, F. 2002. 
Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem 
Biophys Res Commun, 290, 763-9. 
ERICKSON, I. E., HUANG, A. H., CHUNG, C., LI, R. T., BURDICK, J. A. & MAUCK, R. L. 2009. Differential 
maturation and structure-function relationships in mesenchymal stem cell- and 
chondrocyte-seeded hydrogels. Tissue Eng Part A, 15, 1041-52. 
FARRELL, M. J., COMEAU, E. S. & MAUCK, R. L. 2012. Mesenchymal stem cells produce functional 
cartilage matrix in three-dimensional culture in regions of optimal nutrient supply. Eur Cell 
Mater, 23, 425-40. 
FELIMBAN, R., YE, K., TRAIANEDES, K., DI BELLA, C., CROOK, J., WALLACE, G. G., QUIGLEY, A., CHOONG, 
Page 20 of 34
P. F. M. & MYERS, D. E. 2014. Differentiation of stem cells from human infrapatellar fat pad: 
Characterization of cells undergoing chondrogenesis. Tissue Engineering - Part A, 20, 
2213-2223. 
GANNON, A. R., NAGEL, T. & KELLY, D. J. 2012. The role of the superficial region in determining the 
dynamic properties of articular cartilage. Osteoarthritis Cartilage, 20, 1417-25. 
GIMBLE, J. M. & GUILAK, F. 2003. Adipose-derived adult stem cells: isolation, characterization, and 
differentiation potential. Cytotherapy, 5, 362-369. 
GUILAK, F., AWAD, H. A., FERMOR, B., LEDDY, H. A. & GIMBLE, J. M. 2004. Adipose-derived adult stem 
cells for cartilage tissue engineering. Biorheology, 41, 389-99. 
HAUGH, M. G., MEYER, E. G., THORPE, S. D., VINARDELL, T., DUFFY, G. P. & KELLY, D. J. 2011. Temporal 
and spatial changes in cartilage-matrix-specific gene expression in mesenchymal stem cells in 
response to dynamic compression. Tissue Eng Part A, 17, 3085-93. 
HUANG, A. H., FARRELL, M. J., KIM, M. & MAUCK, R. L. 2010. Long-term dynamic loading improves the 
mechanical properties of chondrogenic mesenchymal stem cell-laden hydrogel. Eur Cell 
Mater, 19, 72-85. 
HUANG, C. Y., REUBEN, P. M. & CHEUNG, H. S. 2005. Temporal expression patterns and corresponding 
protein inductions of early responsive genes in rabbit bone marrow-derived mesenchymal 
stem cells under cyclic compressive loading. Stem Cells, 23, 1113-21. 
IGNAT’EVA, N. Y., DANILOV, N. A., AVERKIEV, S. V., OBREZKOVA, M. V., LUNIN, V. V. & SOBOL’, E. N. 2007. 
Determination of hydroxyproline in tissues and the evaluation of the collagen content of the 
tissues. Journal of Analytical Chemistry, 62, 51-57. 
JOHNSTONE, B., HERING, T. M., CAPLAN, A. I., GOLDBERG, V. M. & YOO, J. U. 1998. In vitro 
chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, 238, 
265-72.
JURGENS, W. J. F. M., VAN DIJK, A., DOULABI, B. Z., NIESSEN, F. B., RITT, M. J. P. F., VAN MILLIGEN, F. J. 
& HELDER, M. N. 2009. Freshly isolated stromal cells from the infrapatellar fat pad are 
suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy, 11, 
1052-1064. 
KAFIENAH, W., MISTRY, S., DICKINSON, S. C., SIMS, T. J., LEARMONTH, I. & HOLLANDER, A. P. 2007. 
Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis 
patients. Arthritis Rheum, 56, 177-87. 
KAFIENAH, W. & SIMS, T. J. 2004. Biochemical methods for the analysis of tissue-engineered cartilage. 
Methods Mol Biol, 238, 217-30. 
KELLY, D. J. & JACOBS, C. R. 2010. The role of mechanical signals in regulating chondrogenesis and 
osteogenesis of mesenchymal stem cells. Birth Defects Res C Embryo Today, 90, 75-85. 
KHOSHGOFTAR, M., WILSON, W., ITO, K. & VAN DONKELAAR, C. C. 2012. Influence of tissue- and 
cell-scale extracellular matrix distribution on the mechanical properties of tissue-engineered 
cartilage. Biomech Model Mechanobiol. 
KHOSHGOFTAR, M., WILSON, W., ITO, K. & VAN DONKELAAR, R. 2013. The effects of matrix 
inhomogeneities on the cellular mechanical environment in tissue-engineered cartilage: an in 
silico investigation. Tissue Eng Part C Methods. 
KIM, Y. J., SAH, R. L., DOONG, J. Y. & GRODZINSKY, A. J. 1988. Fluorometric assay of DNA in cartilage 
explants using Hoechst 33258. Anal Biochem, 174, 168-76. 
KISIDAY, J. D., FRISBIE, D. D., MCILWRAITH, C. W. & GRODZINSKY, A. J. 2009. Dynamic compression 
Page 21 of 34
stimulates proteoglycan synthesis by mesenchymal stem cells in the absence of chondrogenic 
cytokines. Tissue Eng Part A, 15, 2817-24. 
LENNON, D. P. & CAPLAN, A. I. 2006. Isolation of human marrow-derived mesenchymal stem cells. Exp 
Hematol, 34, 1604-5. 
LI, J., ZHAO, Z., YANG, J., LIU, J., WANG, J., LI, X. & LIU, Y. 2009. p38 MAPK mediated in compressive 
stress-induced chondrogenesis of rat bone marrow MSCs in 3D alginate scaffolds. J Cell 
Physiol, 221, 609-17. 
LI, Z., KUPCSIK, L., YAO, S. J., ALINI, M. & STODDART, M. J. 2010a. Mechanical load modulates 
chondrogenesis of human mesenchymal stem cells through the TGF-beta pathway. J Cell Mol 
Med, 14, 1338-46. 
LI, Z., YAO, S. J., ALINI, M. & STODDART, M. J. 2010b. Chondrogenesis of human bone marrow 
mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and 
amplitude of dynamic compression and shear stress. Tissue Eng Part A, 16, 575-84. 
LIU, Y., BUCKLEY, C. T., DOWNEY, R., MULHALL, K. J. & KELLY, D. J. 2012. The role of environmental 
factors in regulating the development of cartilaginous grafts engineered using osteoarthritic 
human infrapatellar fat pad-derived stem cells. Tissue Eng Part A, 18, 1531-41. 
LIU, Y., BUCKLEY, C. T., MULHALL, K. J. & KELLY, D. J. 2013. Combining BMP-6, TGF-β3 and hydrostatic 
pressure stimulation enhances the functional development of cartilage tissues engineered 
using human infrapatellar fat pad derived stem cells. Biomaterials Science, 1, 745. 
MATSIKO, A., LEVINGSTONE, T. J., O'BRIEN, F. J. & GLEESON, J. P. 2012. Addition of hyaluronic acid 
improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based 
scaffold for cartilage tissue engineering. Journal of the Mechanical Behavior of Biomedical 
Materials, 11, 41-52. 
MAUCK, R. L., BYERS, B. A., YUAN, X. & TUAN, R. S. 2007. Regulation of cartilaginous ECM gene 
transcription by chondrocytes and MSCs in 3D culture in response to dynamic loading. 
Biomech Model Mechanobiol, 6, 113-25. 
MAUCK, R. L., SOLTZ, M. A., WANG, C. C., WONG, D. D., CHAO, P. H., VALHMU, W. B., HUNG, C. T. & 
ATESHIAN, G. A. 2000. Functional tissue engineering of articular cartilage through dynamic 
loading of chondrocyte-seeded agarose gels. J Biomech Eng, 122, 252-60. 
MAUCK, R. L., YUAN, X. & TUAN, R. S. 2006. Chondrogenic differentiation and functional maturation of 
bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage, 14, 
179-89.
MIKIC, B., ISENSTEIN, A. L. & CHHABRA, A. 2004. Mechanical modulation of cartilage structure and 
function during embryogenesis in the chick. Ann Biomed Eng, 32, 18-25. 
MIKIC, B., JOHNSON, T. L., CHHABRA, A. B., SCHALET, B. J., WONG, M. & HUNZIKER, E. B. 2000. 
Differential effects of embryonic immobilization on the development of fibrocartilaginous 
skeletal elements. J Rehabil Res Dev, 37, 127-33. 
MOW, V. C. & WANG, C. C. 1999. Some bioengineering considerations for tissue engineering of 
articular cartilage. Clin Orthop Relat Res, S204-23. 
PEI, M., HE, F., BOYCE, B. M. & KISH, V. L. 2009. Repair of full-thickness femoral condyle cartilage 
defects using allogeneic synovial cell-engineered tissue constructs. Osteoarthritis Cartilage, 
17, 714-22. 
PEI, M., HE, F. & VUNJAK-NOVAKOVIC, G. 2008. Synovium-derived stem cell-based chondrogenesis. 
Differentiation, 76, 1044-56. 
Page 22 of 34
PELTTARI, K., WINTER, A., STECK, E., GOETZKE, K., HENNIG, T., OCHS, B. G., AIGNER, T. & RICHTER, W. 
2006. Premature induction of hypertrophy during in vitro chondrogenesis of human 
mesenchymal stem cells correlates with calcification and vascular invasion after ectopic 
transplantation in SCID mice. Arthritis Rheum, 54, 3254-66. 
PITTENGER, M. F., MACKAY, A. M., BECK, S. C., JAISWAL, R. K., DOUGLAS, R., MOSCA, J. D., MOORMAN, 
M. A., SIMONETTI, D. W., CRAIG, S. & MARSHAK, D. R. 1999. Multilineage potential of adult
human mesenchymal stem cells. Science, 284, 143-7. 
RIEPPO, J., HYTTINEN, M., HALMESMAKI, E., RUOTSALAINEN, H., VASARA, A., KIVIRANTA, I., JURVELIN, 
J. & HELMINEN, H. 2009. Changes in spatial collagen content and collagen network
architecture in porcine articular cartilage during growth and maturation. Osteoarthritis and 
Cartilage, 17, 448-455. 
SHEEHY, E. J., BUCKLEY, C. T. & KELLY, D. J. 2012. Oxygen tension regulates the osteogenic, 
chondrogenic and endochondral phenotype of bone marrow derived mesenchymal stem cells. 
Biochem Biophys Res Commun, 417, 305-10. 
STECK, E., FISCHER, J., LORENZ, H., GOTTERBARM, T., JUNG, M. & RICHTER, W. 2009. Mesenchymal 
stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to 
bone-close neocartilage. Stem Cells Dev, 18, 969-78. 
STEWARD, A. J., THORPE, S. D., VINARDELL, T., BUCKLEY, C. T., WAGNER, D. R. & KELLY, D. J. 2012. 
Cell-matrix interactions regulate mesenchymal stem cell response to hydrostatic pressure. 
Acta Biomater, 8, 2153-9. 
THORPE, S. D., BUCKLEY, C. T., STEWARD, A. J. & KELLY, D. J. 2012. European Society of Biomechanics 
S.M. Perren Award 2012: the external mechanical environment can override the influence of
local substrate in determining stem cell fate. J Biomech, 45, 2483-92. 
THORPE, S. D., BUCKLEY, C. T., VINARDELL, T., O'BRIEN, F. J., CAMPBELL, V. A. & KELLY, D. J. 2008. 
Dynamic compression can inhibit chondrogenesis of mesenchymal stem cells. Biochem 
Biophys Res Commun, 377, 458-62. 
THORPE, S. D., BUCKLEY, C. T., VINARDELL, T., O'BRIEN, F. J., CAMPBELL, V. A. & KELLY, D. J. 2010. The 
response of bone marrow-derived mesenchymal stem cells to dynamic compression 
following TGF-beta3 induced chondrogenic differentiation. Ann Biomed Eng, 38, 2896-909. 
THORPE, S. D., NAGEL, T., CARROLL, S. F. & KELLY, D. J. 2013. Modulating gradients in regulatory signals 
within mesenchymal stem cell seeded hydrogels: a novel strategy to engineer zonal articular 
cartilage. PLoS One, 8, e60764. 
VINARDELL, T., BUCKLEY, C. T., THORPE, S. D. & KELLY, D. J. 2011. Composition-function relations of 
cartilaginous tissues engineered from chondrocytes and mesenchymal stem cells isolated 
from bone marrow and infrapatellar fat pad. J Tissue Eng Regen Med, 5, 673-683. 
VINARDELL, T., ROLFE, R. A., BUCKLEY, C. T., MEYER, E. G., AHEARNE, M., MURPHY, P. & KELLY, D. J. 
2012a. Hydrostatic pressure acts to stabilise a chondrogenic phenotype in porcine joint tissue 
derived stem cells. Eur Cell Mater, 23, 121-32; discussion 133-4. 
VINARDELL, T., SHEEHY, E. J., BUCKLEY, C. T. & KELLY, D. J. 2012b. A comparison of the functionality and 
in vivo phenotypic stability of cartilaginous tissues engineered from different stem cell 
sources. Tissue Eng Part A, 18, 1161-70. 
WAKITANI, S., GOTO, T., PINEDA, S. J., YOUNG, R. G., MANSOUR, J. M., CAPLAN, A. I. & GOLDBERG, V. 
M. 1994. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage.
J Bone Joint Surg Am, 76, 579-92. 
Page 23 of 34
WICKHAM, M. Q., ERICKSON, G. R., GIMBLE, J. M., VAIL, T. P. & GUILAK, F. 2003. Multipotent Stromal 
Cells Derived From the Infrapatellar Fat Pad of the Knee. Clinical Orthopaedics and Related 
Research, 412, 196-212 10.1097/01.blo.0000072467.53786.ca. 
WISE, J. K., YARIN, A. L., MEGARIDIS, C. M. & CHO, M. 2009. Chondrogenic differentiation of human 
mesenchymal stem cells on oriented nanofibrous scaffolds: engineering the superficial zone 
of articular cartilage. Tissue Eng Part A, 15, 913-21. 
YE, K., FELIMBAN, R., TRAIANEDES, K., MOULTON, S. E., WALLACE, G. G., CHUNG, J., QUIGLEY, A., 
CHOONG, P. F. M. & MYERS, D. E. 2014. Chondrogenesis of infrapatellar fat pad derived 
adipose stem cells in 3D printed chitosan scaffold. PLoS ONE, 9. 
YOO, J. U., BARTHEL, T. S., NISHIMURA, K., SOLCHAGA, L., CAPLAN, A. I., GOLDBERG, V. M. & 
JOHNSTONE, B. 1998. The chondrogenic potential of human bone-marrow-derived 
mesenchymal progenitor cells. J Bone Joint Surg Am, 80, 1745-57. 
Page 24 of 34
Figure 1. Temporal and spatial development of free swelling (FS) cultured BM and 
FP constructs. (A) DNA (ng/mg w/w), sGAG (%w/w) and collagen (%w/w) content 
of FS cultured BM and FP constructs at day 21 and 42; a: p<0.05 vs. same construct 
type at day 21; *: p<0.05, **: p<0.01; ***: p<0.001. (B) Alcian blue, picrosirius red, 
collagen type II and I staining of FS cultured BM and FP constructs at day 42. Scale 
bar in alcian blue, picrosirius red and collagen type II staining: 500 µm. Scale bar in 
collagen type I staining: 50 µm. Inserted images were taken at a low magnification to 
show staining at a bulk construct level, with box regions indicating area from where 
high magnification images were taken. Scale bar in inserted image: 500 µm. 
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Figure 2. Biochemical content and mechanical properties of BM and FP constructs in 
free swelling (FS) and dynamic compression (DC) culture at day 42. (A, H) DNA 
content (ng/mg w/w); (B, I) sGAG content (µg/sample); (C, J) Collagen content 
(µg/sample); (D, K) sGAG content (% w/w); (E, L) Collagen content (% w/w); (F, M) 
Equilibrium modulus (kPa); (G, N) 1Hz dynamic modulus (kPa). *: p<0.05, ***: 
p<0.001. 
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Figure 3. sGAG and collagen content accumulated within the constructs, released 
into media and the total synthesized (accumulated + released) from day 21 to day 42 
in BM and FP constructs in FS and DC culture. (A, C) sGAG content (µg); (B, D) 
collagen content (µg). Media samples from day 21 to day 42 were analysed for sGAG 
or collagen content released from the constructs (n=1 per group, as media from each 
individual construct were pooled). sGAG or collagen content accumulated within 
constructs from day 21 to day 42 were calculated by subtracting the mean value of 
sGAG or collagen content of day 21 samples from the value of sGAG or collagen 
content of each individual day 42 samples (n=4 per group). Total amount of sGAG or 
collagen synthesis from day 21 to day 42 was calculated by summing up the amount 
accumulated within constructs and the amount released into media. *: p<0.05; **: 
p<0.01. 
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Figure 4. Histological and immunohistological staining of BM and FP constructs in 
FS and DC culture at day 42. Scale bar in alcian blue, picrosirius red and collagen 
type II staining: 500 µm. Scale bar in collagen type I staining: 50 µm. Inserted images 
were taken at a low magnification to show staining at a bulk construct level, with box 
regions indicating area from where high magnification images were taken. Scale bar 
in inserted image: 500 µm. 
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Figure 5. Biochemical content of top and bottom halves of BM and FP constructs, 
engineered using both donors, in FS and DC culture at day 42. (A, C, E, G) sGAG 
content (%w/w); (B, D, F, H) collagen content (%w/w). +: p<0.1; *: p<0.05, **: 
p<0.01; ***: p<0.001. 
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Figure 6. Assessment of mineralization in BM and FP constructs, engineered using 
both donors, in FS and DC culture at day 42. (A) Representative alizarin red staining 
of mineral deposition in BM and FP constructs in FS and DC culture at day 42; scale 
bar: 500 µm. (B) 3D images obtained with µCT scanning of mineral deposition within 
BM constructs in FS and DC culture. Scale bar: 1mm. (C) Volume of minerals within 
BM constructs in FS and DC culture. Two constructs per group were scanned using 
µCT. 
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Supplementary Figure 1. Temporal and spatial development of free swelling (FS) 
cultured BM and FP constructs engineered using donor 2. (A) DNA (ng/mg w/w), 
sGAG (%w/w) and collagen (%w/w) content of FS cultured BM and FP constructs 
from donor 2 at day 21 and 42; a: p<0.05 vs. same construct type at day 21; *: p<0.05, 
**: p<0.01; ***: p<0.001. (B) Alcian blue, picrosirius red, collagen type II and I 
staining of FS cultured BM and FP constructs from donor 2 at day 42. Scale bar in 
alcian blue, picrosirius red and collagen type II staining: 500 µm. Scale bar in 
collagen type I staining: 50 µm. Inserted images were taken at a low magnification to 
show staining at a bulk construct level, with box regions indicating area from where 
high magnification images were taken. Scale bar in inserted image: 500 µm. 
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Supplementary Figure 2. Biochemical content and mechanical properties of BM and 
FP constructs, engineered using donor 2, in FS and DC culture at day 42. (A, H) DNA 
content (ng/mg w/w); (B, I) sGAG content (µg/sample); (C, J) Collagen content 
(µg/sample); (D, K) sGAG content (% w/w); (E, L) Collagen content (% w/w); (F, M) 
Equilibrium modulus (kPa); (G, N) 1Hz dynamic modulus (kPa).  
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Supplementary Figure 3. Histological and immunohistological staining of BM and 
FP constructs, engineered using donor 2, in FS and DC culture at day 42. Scale bar in 
alcian blue, picrosirius red and collagen type II staining: 500 µm. Scale bar in 
collagen type I staining: 50 µm. Inserted images were taken at a low magnification to 
show staining at a bulk construct level, with box regions indicating area from where 
high magnification images were taken. Scale bar in inserted image: 500 µm. 
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Supplementary Figure 4. Alcian blue and picrosirius red staining at the peripheral 
region of BM constructs in FS and DC culture at day 42. Images in first and third row 
were taken at a low magnification, showing staining at a bulk construct level; scale 
bar: 500 µm. Images in second and fourth row were taken at a high magnification, 
showing staining at the peripheral region of the constructs; scale bar: 50 µm. 
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